Industry 4.0 has the potential to create $3.7 trillion in value from the redefinition of every market, and this transition will happen with speed and inevitability. Additive manufacture, as a key industry 4.0 technology, will make a critical contribution to accessing this new value.
BiologIC is pioneering the second wave of additive, leveraging the technology in new ways to rapidly design, test, build and iterate new products that are disrupting industries.
The lead market is life sciences. According to McKinsey, 60% of all the physical inputs into the global economy could be produced using biology. BiologIC is developing the world’s first biocomputer which addresses huge unmet demand for bioprocessing power in vaccines, diagnostics, drug discovery, cell and gene therapy, lab grown food, DNA data storage and synthetic biology.
BiologIC’s full stack digital platform is being used by a rapidly growing ecosystem of partners wishing to reimagine what’s possible, innovate at the speed of thought and accelerate their speed to market.
We warmly welcome new members of the innovation community into our rapidly growing ecosystem. Join us at www.biologic-tech.com